Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying ...

CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP ...

Sept 23 (Reuters) - Moderna (MRNA.O), opens new tab said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in ...

The agreement includes a Memorandum of Understanding that supports “Plan Mexico,” aimed at building a local mRNA ecosystem and enabling access to Moderna’s respiratory vaccine portfolio. Moderna and ...

The updated formula for Moderna’s COVID-19 vaccine generates a 16-fold increase in antibodies that neutralize the intended SARS-CoV-2 variant target among recipients, according to a press release from ...

Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health security Strategic agreement will enable access to ...

Pfizer Inc.'s (NYSE:PFE) COVID-19 vaccine for children under five may lose U.S. Food and Drug Administration authorization this fall, raising the possibility of supply shortages and prompting Moderna ...

Vaccine-maker Moderna has opened a new manufacturing base in Oxfordshire in a boost to the pharmaceutical industry after other major firms shelved or paused planned UK investments this year. The ...